NOTCH1 and glioblastoma: In line with this, knockdown of DR5 using a DR5-specific siRNA oligonucleotide completely abrogated the sensitization of cells to TRAIL-mediated apoptosis upon Notch1 inhibition (Figure 2g) confirming DR5 as the main signal transducing TRAIL receptor in glioblastomas.